Breast Cancer Perspective

• Are the Physicians to Blame for the Patient's Failure to Follow Up? In this case, physicians performed three scans, so how was the patient's cancer missed?
  The Doctors Company, September 20, 2021
• Defining Optimal Therapy in High-Risk Early Breast Cancer: Bonus Content: A Promising Horizon   Stanford oncologists discuss strategies for selecting new targeted therapies and opportunities to de-escalate chemotherapy in high-risk breast cancer.
  Medscape TV, September 14, 2021
• Breast Cancer in Black Women: Physicians Do Not Know Enough Breast cancer disproportionately limits the survival of Black women. We need to understand why.
  Medscape Blogs, September 14, 2021
• Early Cancer Drug Results: Are We Celebrating Too Soon? How we can spot limitations in new clinical trial findings.
  Medscape Oncology, September 10, 2021
• This Oncologist Created a Legacy for a Beloved Patient   Our cameras captured the inspiring journey of one doctor determined to help her patient live on, even after her death.
  Medscape Oncology, September 09, 2021
• Skill Checkup: A 64-Year-Old Woman With a Breast Mass and Back and Hip Pain A 64-year-old postmenopausal woman presents with a breast mass on mammography and pain in her back and hip. How would you manage her case?
  Medscape Oncology, September 08, 2021
• We Need to Level With Our Patients About Tumor Sequencing   A recent look at the real-world benefits of tumor sequencing suggests that it may be a mixed bag for patients, says Dr Kathy Miller.
  Medscape Oncology, August 27, 2021
• Looking for a Good Read? Two End-of-Summer Book Recommendations   Dr Kathy Miller provides two end-of-summer science book club recommendations.
  Medscape Oncology, August 26, 2021
• Myth or Fact: Nurses Make the Worst Patients Have nurses gotten a bad rap? This seasoned nurse believes that the reputation of nurses as 'worst possible' patients may be undeserved and only partially explains the story of hospitalized colleagues.
  Medscape Blogs, August 18, 2021
• Emerging Treatments for OMBC: Where Are We Now? Breast cancer specialist Igor Makhlin, MD, discusses the poorly understood entity of oligometastatic breast cancers and provides insights on evolving research and current treatment strategies.
  Medscape Oncology, August 05, 2021
• Oncologists Face Nightmares Every Day With Prior Authorization An oncologist describes the frustration of having insurance companies deny tests and drugs that he has ordered: "A part of every day is spent worrying."
  Medscape Oncology, August 04, 2021
• Women’s Health: 50 Years of Progress   Part of the National Academy of Medicine’s look back at a half century of progress in health, this report focuses on women.
  Medscape Ob/Gyn, July 30, 2021
• COVID-19 and Cancer Misinformation: An Oncologist's Viewpoint An oncologist reflects on the endemic of cancer misinformation in our society and the parallels with COVID-19 pandemic misinformation, and where we may have gone wrong in our public health messaging.
  Medscape Blogs, July 27, 2021
• Cancer Therapy and Myocardial Dysfunction: 5 Things to Know An expert overview of some key aspects to preventing, monitoring, and managing cardiac dysfunction related to cancer therapy.
  American College of Cardiology & Medscape , July 26, 2021
• Ovarian Cancer Management: We Have Come So Far   Gynecologic oncologist Dr Shannon Westin considers how far ovarian cancer management has come since she was in medical school, and speaks to the areas that still need to be addressed.
  Medscape, June 29, 2021
• Key Studies in Early Breast Cancer From ASCO 2021   Dr Harold Burstein highlights studies in early breast cancer from ASCO 2021, including adjuvant olaparib in HR+/HER2- disease, neoadjuvant therapy in TNBC, and therapy de-escalation in HER2+ disease.
  Medscape, June 28, 2021
• Highlights in Metastatic Breast Cancer From ASCO 2021   Metastatic breast cancer highlights from ASCO 2021 include updated CDK4/6 inhibitor survival data, endocrine therapy in HR+/HER2+ disease, and a subanalysis of ASCENT, as discussed by Dr Lisa Carey.
  Medscape, June 28, 2021
• The Two Greatest Challenges in Managing Ovarian Cancer   Gynecologic oncologist Dr Shannon Westin reveals her two greatest challenges when facing patients with ovarian cancer: early detection and finding the right treatment for the right patient.
  Medscape, June 25, 2021
• Key Strategies for Managing Breast Cancer Brain Metastases Breast cancer specialist Kevin M. Kalinsky, MD, discusses the interplay of tumor characteristics and treatment options.
  Medscape Oncology, June 17, 2021
• ASCO 2021 For Residual TNBC Post-Chemo, Capecitabine Should Be Offered   For high-risk patients with triple-negative breast cancer who have residual disease following neoadjuvant therapy, Dr Kathy Miller says we must accept capecitabine as the standard of care.
  Medscape Oncology, June 15, 2021